5
Clinical Trials associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.) / Active, not recruitingPhase 3 A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged From 6 Months to 5 Years
The purpose of this study is to evaluate the immunogenicity and safety of Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.
/ Active, not recruitingPhase 3 单中心、随机、盲法、阳性对照评价A群C群脑膜炎球菌多糖结合疫苗在3-5月龄婴幼儿中安全性和免疫原性的Ⅲ期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase III clinical trial to evaluate the safety and immunogenicity of group A and group C meningococcal polysaccharide conjugate vaccine in infants aged 3-5 months
单中心、随机、盲法、阳性对照评价A群C群脑膜炎球菌多糖结合疫苗在3-5月龄婴幼儿中安全性和免疫原性的Ⅲ期临床试验
[Translation] A single-center, randomized, blinded, positive-controlled phase III clinical trial to evaluate the safety and immunogenicity of group A and group C meningococcal polysaccharide conjugate vaccines in infants aged 3-5 months
/ Active, not recruitingPhase 3 A Single-center, Randomized, Blind, Positive Control Phase III Clinical Trial to Evaluate Immunogenicity and Safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in Volunteers Aged 3-5 Months
The purpose of this study is to evaluate the immunogenicity and safety of Group A and C Meningococcal Polysaccharide Conjugate Vaccine in healthy volunteers aged from 3 to 5 months old.
100 Clinical Results associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Translational Medicine associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Patents (Medical) associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)
100 Deals associated with Group A and C Meningococcal Polysaccharide Vaccine(Beijing Luzhu Biopharmaceutical Co., Ltd.)